ARQIS advises the shareholders of Medizintechnik Rostock on the sale to SHS Capital
ARQIS advises the shareholders of Medizintechnik Rostock on the sale to SHS Capital
28. November 2024
ARQIS advised the shareholders of Medizintechnik Rostock GmbH (MTR) on all legal aspects of the sale of a majority stake to SHS Gesellschaft für Beteiligungsmanagement mbH. SHS is acquiring the stake for its sixth generation of funds (SHS IV), thus securing the continuity of MTR. The two previous shareholders and Managing Directors of MTR will continue to be associated with MTR through a significant shareholding. The parties have agreed not to disclose further details of the transaction, such as the purchase price.
Medizintechnik Rostock GmbH, with main locations in Rostock and Berlin, is a medium-sized company that provides patients with therapy devices for domestic use. MTR is one of the leading therapy and rehabilitation providers and, as a partner of 80 health insurance companies, provided over 140,000 treatments in movement, electro and compression therapy in 2023.
SHS Gesellschaft für Beteiligungsmanagement mbH, based in Tübingen, is a private equity fund that specializes in investments in the healthcare sector. SHS is currently investing from its sixth fund, which was launched in 2022 and has a volume of around €270 million.
The shareholders and MTR have been advised on healthcare law for many years by a team from D+B Rechtsanwälte Partnerschaft mbB headed by Dr. Ulrich Grau, who recommended ARQIS for this transaction. The team headed by Dr. Jörn-Christian Schulze then successfully pitched.
Advisor to Medizintechnik Rostock GmbH
ARQIS (Dusseldorf): Core Deal Team: Dr. Jörn-Christian Schulze (Lead, Transactions), Severin Steffens (Managing Associate, Transactions), Jasmin Grünen (Associate, Transactions), Partner: Thomas Chwalek (Transactions), Dr. Ulrich Lienhard (Real estate), Marcus Nothhelfer (IP), Counsel: Jens Knipping, Dennis Reisich (both Tax), Anja Mehrtens (HR Law), Managing Associates: Tim Bresemann, Diana Puchowezki (both Real Estate), Daniel Schlemann (Data Law), Nora Stratmann (Commercial), Rolf Tichy (IP), Martin Weingärtner (Pensions), Associates: Rebecca Gester (Commercial), Thomas Lipsky (IP), Jasmin Grünen (Transactions), Sabine Müller, Dr. Hendrik Völkerding (both HR Law), Senior Legal Specialist: Qing Xia (Transactions)
D+B D+B (Berlin): Dr. Ulrich Grau (Lead), Nicole Jesche, Tatjana Teterjukow, Franziska Dickmann (all Healthcare Law), Dr. Sabrina Neuendorf (Data Protection Law)